Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.21.2
Consolidated Statements of Operations - USD ($)
12 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Income Statement [Abstract]    
Revenues $ 26,257,000 $ 16,842,000
Cost of sales 20,467,000 14,656,000
Gross profit 5,790,000 2,186,000
Operating expenses:    
Selling and administrative 12,599,000 9,761,000
Research and development 6,669,000 4,973,000
Total operating expenses 19,268,000 14,734,000
Operating loss (13,478,000) (12,548,000)
Other income (expense):    
Other income 1,307,000
Interest expense (622,000) (1,788,000)
Net loss $ (12,793,000) $ (14,336,000)
Net loss per share - basic and diluted $ (1.08) $ (2.80)
Weighted average number of common shares outstanding - basic and diluted 11,796,217 5,118,713